SavedAdd your journal

Journals / ANKEM Dergisi / 2010 / Cilt: 24 - Sayı: 3

Antibiotic treatment in postoperative pneumonia

Postoperatif pnömonide antibiyotik tedavisi

İftihar KÖKSAL
Pages
162–168
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Commonly, treatment has to be started without waiting for culture results and, if necessary, should be subsequently modified depending on the later.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pneumonia is a frequent complication after major surgery or injury.
📊
Key Findings & Data:Mortality associated with pneumonia in surgical patients ranges from 10 % to 18 %.
💡
Conclusion & Impact:Commonly, treatment has to be started without waiting for culture results and, if necessary, should be subsequently modified depending on the later.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pneumonia is a frequent complication after major surgery or injury. Mortality associated with pneumonia in surgical patients ranges from 10 % to 18 %. Appropriate antibiotic therapy significantly improves survival for patients with postoperative pneumonia. The empirical choice of the most appropriate antibiotic agent at the outset is crucial, because studies showed a higher mortality rate in patients treated initially with an inappropriate antibiotic. Commonly, treatment has to be started without waiting for culture results and, if necessary, should be subsequently modified depending on the later.

Özet

Pnömoni büyük cerrahi veya yaralanmalardan sonra sık görülen bir komplikasyondur. Cerrahi girişim yapılan hastalarda pnömoni ile ilişkili mortalite hızı % 10-18 arasındadır. Doğru antibiyotik tedavisi postoperatif pnömonili hastalarda surviyi önemli oranda iyileştirmektedir. Çalışmalar, uygun olmayan antibiyotiklerle tedaviye başlanan hastalarda mortalite oranlarının yüksek olduğunu gösterdiğinden başlangıçta seçilecek en uygun ampirik antibiyotik tedavisi çok önemlidir. Çoğunlukla tedavi, kültür sonuçları beklenmeden başlanmalı ve gerekirse sonradan modifiye edilmelidir. *25.ANKEM Antibiyotik ve Kemoterapi Kongresi, Yatay İnteraktif Kurs 1C sunularından (28 Nisan-02 Mayıs 2010, Kuzey Kıbrıs Türk Cumhuriyeti)

🔖

Cite This Article

KÖKSAL, İ. (2010). Antibiotic treatment in postoperative pneumonia. ANKEM Dergisi, Cilt: 24 - Sayı: 3, 162–168. https://ajindex.com/articles/355070

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. American Thoracic Society: Guidelines for the management of adult with hospital acquired, ventilator-associated and healthcare-associated pneumonia, Am J Respir Crit Care Med 2005; 171(4):388-416
  2. Chastre J: Antimicrobial treatment of hospital-acquired pneumonia, Infect Dis Clin North Am 2003;17(4):727-37
  3. Chastre J, Wolff M, Fagon J et al: Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults, JAMA 2003; 290(19):2588-98
  4. Celis R, Torres A, Gatell J et al: Nosocomial pneumonia: a multivariate analysis of risk and prognosis, Chest 1988;93(2):318-24
  5. Combes A, Luyt C, Fagon J et al: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia, Crit Care Med 2007;35(1):146-54
  6. Croce MA, Fabian TC, Stewart RM et al: Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients, J Trauma 1993;35(2):303-9
  7. Dupont H, Montravers P, Gauzit R, Veber B, Pouriat JL, Martin C, Club d’Infectiologie en Anesthesie-Reanimation: Outcome of postoperative pneumonia in the Eole study, Intensive Care Med 2003;29(2):179-88
  8. Falagas ME, Kasiakou SK: Colistin the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections, Clin Infect Dis 2005;40(9):1333-41
  9. Fisher BW, Majumdar SR, McAlister FA: Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies, Am J Med 2002;112(3):219-25
  10. French GL: Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin, J Antimicrob Chemother 2006;58(3):1107-17
  11. Garcia JCP, Filho OFF, Grion CMC et al: Impact of the implementation of a therapeutic guideline on the treatment of nosocomial pneumonia acquired in the intensive care unit of a university hospital, J Bras Pneumol 2007;33(2):175-84
  12. Garnacho-Montero, J, Sa-Borges, M, Sole-Violan J et al: Optimal management therapy for Pseudo-monas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy, Crit Care Med 2007;35(8):1888-95
  13. Giantsou E, Liratzopoulos N, Efraimidou E et al: De-escalation therapy rates are significantly higher by bronchalveolar lavage than by tracheal aspiration, Intensive Care Med 2007;33(9):1533-40
  14. Heyland DK, Dodek P, Muscedere J et al: Randomized trial of combination versus mono-therapy for the empiric treatment of suspected venti